{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:39:55Z","timestamp":1753889995229,"version":"3.41.2"},"reference-count":22,"publisher":"IMR Press","issue":"1","license":[{"start":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T00:00:00Z","timestamp":1617062400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Cardiovasc. Med."],"abstract":"<jats:p>Sildenafil citrate and its generic forms are widely used to treat erectile dysfunction worldwide. Sildenafil citrate associated myocardial infarction is rarely reported in patients with no previous coronary artery disease. Herein, we present a case of a 40-year-old man with no cardiovascular risk factors other than heavy smoking and heavy drinking with no known previous ischemic symptoms, who had an ST-segment elevation myocardial infarction after receiving sildenafil citrate. From this case report, we emphasize that as sildenafil is increasingly being used as a recreational drug as it is widely available without a physician\u2019s prescription, physicians should be aware that it may reveal the underlying cardiovascular problem. Thus, physicians must also consider the underlying medical conditions when prescribing sildenafil.<\/jats:p>","DOI":"10.31083\/j.rcm.2021.01.286","type":"journal-article","created":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T00:44:00Z","timestamp":1617324240000},"source":"Crossref","is-referenced-by-count":2,"title":["Sildenafil-triggered multi-culprit ST-segment elevation myocardial infarction: a case report"],"prefix":"10.31083","volume":"22","author":[{"given":"Byung Woo","family":"Yoon","sequence":"first","affiliation":[{"name":"Division of Hemato-Oncology, Department of Internal Medicine, Seoul Paik Hospital, 04551 Seoul, Republic of Korea"},{"name":"Inje University, College of Medicine, 47392 Busan, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Yeon","family":"Hong","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Nowon Eulji Medical Center, Eulji University, 01830 Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"16242","published-online":{"date-parts":[[2021,3,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Park K, Hwang EC, Kim S. Prevalence and medical management of erectile dysfunction in Asia. Asian Journal of Andrology. 2011; 13: 543-549.","DOI":"10.1038\/aja.2010.131"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Ayta IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU International. 1999; 84: 50-56.","DOI":"10.1046\/j.1464-410x.1999.00142.x"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. New England Journal of Medicine. 1998; 338: 1397-1404.","DOI":"10.1056\/NEJM199805143382001"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Morales A, Gingell C, Collins M, Wicker PA, Osterloh IH. Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction Sildenafil Study Group. International Journal of Impotence Research. 1998; 10: 69-64.","DOI":"10.1038\/sj.ijir.3900354"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Cheitlin MD, Hutter AM, Brindis RG, Ganz P, Kaul S, Russell RO, et al. Use of sildenafil (Viagra) in patients with cardiovascular disease. Technology and Practice Executive Committee. Circulation. 1999; 99: 168-177.","DOI":"10.1161\/01.CIR.99.1.168"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Jackson G, Montorsi P, Cheitlin MD. Cardiovascular safety of sildenafil citrate (Viagra): an updated perspective. Urology. 2006; 68: 47-60.","DOI":"10.1016\/j.urology.2006.05.047"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Mittleman MA, Glasser DB, Orazem J. Clinical trials of sildenafil citrate (Viagra) demonstrate no increase in risk of myocardial infarction and cardiovascular death compared with placebo. International Journal of Clinical Practice. 2003; 57: 597-600.","DOI":"10.1111\/j.1742-1241.2003.tb10566.x"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Mittleman MA, Maclure M, Glasser DB. Evaluation of acute risk for myocardial infarction in men treated with sildenafil citrate. American Journal of Cardiology. 2005; 96: 443-446.","DOI":"10.1016\/j.amjcard.2005.03.097"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Kekilli M, Beyazit Y, Purnak T, Dogan S, Atalar E. Acute myocardial infarction after sildenafil citrate ingestion. The Annals of Pharmacotherapy. 2005; 39: 1362-1364.","DOI":"10.1345\/aph.1E665"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Schwartz BG, Kloner RA. Drug interactions with phosphodiesterase-5 inhibitors used for the treatment of erectile dysfunction or pulmonary hypertension. Circulation. 2010; 122: 88-95.","DOI":"10.1161\/CIRCULATIONAHA.110.944603"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Cheitlin MD, Hutter AM, Brindis RG, Ganz P, Kaul S, Russell RO, et al. ACC\/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology\/American Heart Association. Journal of the American College of Cardiology. 1999; 33: 273-282.","DOI":"10.1016\/S0735-1097(98)00656-1"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Ahn TY, Park JK, Lee SW, Hong JH, Park NC, Kim JJ, et al. Prevalence and risk factors for erectile dysfunction in Korean men: results of an epidemiological study. Journal of Sexual Medicine. 2007; 4: 1269-1276.","DOI":"10.1111\/j.1743-6109.2007.00554.x"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Cho BL, Kim YS, Choi YS, Hong MH, Seo HG, Lee SY, et al. Prevalence and risk factors for erectile dysfunction in primary care: results of a Korean study. International Journal of Impotence Research. 2003; 15: 323-328.","DOI":"10.1038\/sj.ijir.3901022"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Leslie SJ, Atkins G, Oliver JJ, Webb DJ. No adverse hemodynamic interaction between sildenafil and red wine. Clinical Pharmacology and Therapeutics. 2004; 76: 365-370.","DOI":"10.1016\/j.clpt.2004.07.005"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Iglesias ML, Jeric\u00f3 C, Skaf E, Pedro-Botet J. Sildenafil and coronary artery disease. BJU International. 2003; 92: 824-825.","DOI":"10.1046\/j.1464-410X.2003.t01-5-04488.x"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Brindis RG, Kloner RA. Sildenafil in patients with cardiovascular disease. American Journal of Cardiology. 2003; 92: 26M-36M.","DOI":"10.1016\/S0002-9149(02)03368-4"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Giuliano F, Jackson G, Montorsi F, Martin-Morales A, Raillard P. Safety of sildenafil citrate: review of 67 double-blind placebo-controlled trials and the postmarketing safety database. International Journal of Clinical Practice. 2010; 64: 240-255.","DOI":"10.1111\/j.1742-1241.2009.02254.x"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Hayat S, Al-Mutairy M, Zubaid M, Suresh C. Acute Myocardial infarction following sildenafil intake in a nitrate-free patient without previous history of coronary artery disease. Medical Principles and Practice. 2007; 16: 234-236.","DOI":"10.1159\/000100397"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Porter A, Mager A, Birnbaum Y, Strasberg B, Sclarovsky S, Rechavia E. Acute myocardial infarction following sildenafil citrate (viagra\u00ae) intake in a nitrate-free patient. Clinical Cardiology. 1999; 22: 762-763.","DOI":"10.1002\/clc.4960221122"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Werner GS, Figulla HR. Direct assessment of coronary steal and associated changes of collateral hemodynamics in chronic total coronary occlusions. Circulation. 2002; 106: 435-440.","DOI":"10.1161\/01.CIR.0000022848.92729.33"},{"key":"ref21","unstructured":"Ueno M. The so-called coition death. Nihon Hoigaku Zasshi. 1996; 17: 330-340. (In Japanese)"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Groom KM, Ganzevoort W, Alfirevic Z, Lim K, Papageorghiou AT. Clinicians should stop prescribing sildenafil for fetal growth restriction (FGR): comment from the STRIDER Consortium. Ultrasound in Obstetrics & Gynecology. 2018; 52: 295-296.","DOI":"10.1002\/uog.19186"}],"container-title":["Reviews in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/22\/1\/10.31083\/j.rcm.2021.01.286","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T17:13:26Z","timestamp":1732727606000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/22\/1\/10.31083\/j.rcm.2021.01.286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,30]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"alternative-id":["1617068733146-479764894"],"URL":"https:\/\/doi.org\/10.31083\/j.rcm.2021.01.286","relation":{},"ISSN":["1530-6550","2153-8174"],"issn-type":[{"type":"print","value":"1530-6550"},{"type":"electronic","value":"2153-8174"}],"subject":[],"published":{"date-parts":[[2021,3,30]]},"article-number":"185"}}